InvivoSciences

About:

We provide phenotypic compound screening services for first-in-class drug discovery and drug repositioning

Website: http://invivosciences.com/

Top Investors: MassChallenge

Description:

We provide phenotypic compound screening services for first-in-class drug discovery and drug repositioning. Our unique combination of tissue engineering technology with assay automation and sample miniaturization offers a rapid and cost effective platform for unprecedented therapeutic discovery.As our name implies, the core of InvivoSciences mission is the research and development of engineered tissue-based assays that are superior because they mimic the function of living organisms, specifically those of animals and humans.

Total Funding Amount:

$700000

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Madison, Wisconsin, United States

Founded Date:

2001-01-01

Contact Email:

aannac(AT)invivosciences.com

Founders:

Ayla Annac, Elliot Elson, Tetsuro Wakatsuki

Number of Employees:

1-10

Last Funding Date:

2020-10-21

IPO Status:

Private

Industries:

© 2025 bioDAO.ai